FDG PET/CT appearance of local osteosarcoma recurrences in pediatric patients
- PMID: 28887617
- DOI: 10.1007/s00247-017-3963-1
FDG PET/CT appearance of local osteosarcoma recurrences in pediatric patients
Abstract
Background: Osteosarcoma is the most common pediatric malignant bone tumor, frequently surgically managed with limb salvage rather than amputation. Local recurrences are seen in up to 9% of osteosarcoma patients, with CT and MRI imaging often limited by metal artifacts.
Objective: To describe the [F-18]2-fluoro-2-deoxyglucose (FDG) PET/CT appearance of local osteosarcoma recurrences with correlation to findings on other imaging modalities.
Materials and methods: A retrospective review of pediatric osteosarcoma patients imaged with FDG PET/CT was performed in patients with pathologically proven local recurrences. FDG PET/CT findings were reviewed and correlated with available comparison imaging studies.
Results: Ten local osteosarcoma recurrences in eight pediatric osteosarcoma patients were imaged with FDG PET/CT. All eight patients had a local recurrence after limb salvage; two patients had a second local recurrence after amputation. All local recurrences were seen with FDG PET/CT, demonstrating solid (n=5) or peripheral/nodular (n=5) FDG uptake patterns. Maximum standard uptake values (SUVs) ranged from 3.0 to 15.7. In five recurrences imaged with FDG PET/CT and MRI, MRI was limited or nondiagnostic in three. In four recurrences imaged with FDG PET/CT and bone scan, the bone scan was negative in three.
Conclusion: Local osteosarcoma recurrences are well visualized by FDG PET/CT, demonstrating either solid or peripheral/nodular FDG uptake with a wide range of maximum SUVs. FDG PET/CT demonstrates the full extent of local recurrences, while MRI can be limited by artifact from metallic hardware. PET/CT appears to be more sensitive than bone scan in detecting local osteosarcoma recurrences.
Keywords: Children; Fluorodeoxyglucose positron emission tomography/computed tomography; Local recurrence; Osteosarcoma.
Similar articles
-
Effectiveness of 18F-FDG PET/CT in the diagnosis and staging of osteosarcoma: a meta-analysis of 26 studies.BMC Cancer. 2019 Apr 5;19(1):323. doi: 10.1186/s12885-019-5488-5. BMC Cancer. 2019. PMID: 30953476 Free PMC article.
-
Comparison of (18) F-FDG-PET-CT and Bone Scintigraphy for Evaluation of Osseous Metastases in Newly Diagnosed and Recurrent Osteosarcoma.Pediatr Blood Cancer. 2016 Aug;63(8):1381-6. doi: 10.1002/pbc.26014. Epub 2016 Apr 15. Pediatr Blood Cancer. 2016. PMID: 27082077 Free PMC article.
-
[F-18]2-fluoro-2-deoxyglucose (FDG) positron emission tomography after limb salvage surgery: post-surgical appearance, attenuation correction and local complications.Pediatr Radiol. 2015 Jul;45(8):1182-8. doi: 10.1007/s00247-015-3290-3. Epub 2015 Feb 27. Pediatr Radiol. 2015. PMID: 25721581
-
18F-FDG PET/CT in the Management of Osteosarcoma.J Nucl Med. 2023 Jun;64(6):842-851. doi: 10.2967/jnumed.123.265592. Epub 2023 May 18. J Nucl Med. 2023. PMID: 37201958 Review.
-
The Utility of 18FDG PET/CT Versus Bone Scan for Identification of Bone Metastases in a Pediatric Sarcoma Population and a Review of the Literature.J Pediatr Hematol Oncol. 2021 Mar 1;43(2):52-58. doi: 10.1097/MPH.0000000000001917. J Pediatr Hematol Oncol. 2021. PMID: 32815877 Review.
Cited by
-
18F-FDG PET-CT in paediatric oncology: established and emerging applications.Br J Radiol. 2019 Feb;92(1094):20180584. doi: 10.1259/bjr.20180584. Epub 2018 Nov 28. Br J Radiol. 2019. PMID: 30383441 Free PMC article. Review.
-
The role of positron emission tomography in the evaluation and management of musculoskeletal lesions-a narrative review.Ann Jt. 2025 Jan 21;10:8. doi: 10.21037/aoj-24-26. eCollection 2025. Ann Jt. 2025. PMID: 39981426 Free PMC article. Review.
-
Functional and anatomical imaging in pediatric oncology: which is best for which tumors.Pediatr Radiol. 2019 Oct;49(11):1534-1544. doi: 10.1007/s00247-019-04489-z. Epub 2019 Oct 16. Pediatr Radiol. 2019. PMID: 31620853 Review.
-
Imaging characteristics of tenosynovial giant cell tumors on 18F-fluorodeoxyglucose positron emission tomography/computed tomography: a retrospective observational study.BMC Musculoskelet Disord. 2023 Jul 19;24(1):593. doi: 10.1186/s12891-023-06730-1. BMC Musculoskelet Disord. 2023. PMID: 37468883 Free PMC article.
-
Differential Diagnosis of Lipomatous Tumors Using 18F-Fluorodeoxygulcose Positron Emission Tomography/Computed Tomography: A Retrospective Observational Study.Cancer Diagn Progn. 2024 Mar 3;4(2):141-146. doi: 10.21873/cdp.10300. eCollection 2024 Mar-Apr. Cancer Diagn Progn. 2024. PMID: 38434912 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
